Covariates of amikacin clearance in neonates: The impact of postnatal age on predictability

Drug Metabolism Letters

Volumn 2, Issue 4, 2008, Pages 286-289

  Allegaert, Karel ^a   Scheers, Isabelle ^a   Cossey, Veerle ^a   Anderson, Brian J ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Amikacin; Covariates; Ontogeny; Predictability; Renal drug clearance

Indexed keywords

AMIKACIN; DOPAMINE; IBUPROFEN; ANTIINFECTIVE AGENT;

AGE; ARTICLE; ARTIFICIAL VENTILATION; BODY SIZE; BODY WEIGHT; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; HUMAN; INTRAUTERINE GROWTH RETARDATION; KIDNEY CLEARANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; PERINATAL PERIOD; PLASMA CONCENTRATION-TIME CURVE; PREDICTION; PRIORITY JOURNAL; BIOLOGICAL MODEL; FACTUAL DATABASE; FORECASTING;

AGE FACTORS; AMIKACIN; ANTI-BACTERIAL AGENTS; DATABASES, FACTUAL; FORECASTING; HUMANS; INFANT, NEWBORN; MODELS, BIOLOGICAL;

EID: 65249142153     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231208786734157     Document Type: Article

References (24)

1. Kearns, G. L.; Abdel-Rahman, S. M.; Alander, S. W.; Blowey, D. L.; Leeder, J. S.; Kauffman, R. E. N. Engl. J. Med., 2003, 349, 1157.
2. Koren, G.; James, A.; Perlman, M. Clin. Pharmacol. Ther., 1985, 38: 680.
3. Guignard, J. P.; Drukker, A. Pediatrics, 1999, 103, e49.
4. Van den Anker, J. N. Acta Paediatr., 1996, 85, 1393.
5. Arant, B. S. Jr. J. Pediatr., 1978, 92, 705.
6. Sonntag, J.; Prankel, B.; Waltz, S. Eur. J. Pediatr., 1996, 155, 815.
7. van der Heijden, A. J.; Grose, W. F.; Ambagtsheer, J. J.; Provoost, A. P.; Wolff, E. D.; Sauer, P. J. Eur. J. Pediatr., 1988, 148, 24.
8. Van den Anker, J. N.; de Groot, R.; Broerse, H. M.; Sauer, P. J.; van der Heijden, B. J.; Hop, W. C.; Lindemans, J. Pediatrics, 1995, 96, 1156.
9. Allegaert, K.; Anderson, B. J. Eur. J. Clin. Pharmacol., 2006, 62, 1011.
10. Bleyzac, N.; Varnier, V; Labaune, J. M.; Corvaisier, S.; Maire, P.; Jelliffe, R. W.; Putet, G.; Aulagner, G. Eur. J. Clin. Pharmacol., 2001, 57, 499.
11. de Hoog, M.; Mouton, J. W., Van den Anker, J. N. Clin. Pharmacokinet., 2004, 43, 417.
12. Allegaert, K.; Anderson, B. J.; Cossey, V.; Holford, N. H. Br. J. Clin. Pharmacol., 2006, 61, 39.
13. Anderson, B. J.; Allegaert, K.; Van den Anker, J. N.; Cossey, V.; Holford, N. H. Br. J. Clin. Pharmacol., 2007, 63, 75.
14. Langhendries, J. P.; Battisti, O.; Bertrand, J. M.; Francois, A.; Kalenga, M.; Darimont, J.; Scalais, E.; Wallemacq, P. Biol. Neonate., 1998, 74, 351.
15. Anderson, B. J.; Allegaert, K.; Holford, N. H. Eur. J. Pediatr., 2006, 165, 819.
16. Beal, S. L.; Sheiner, L. B.; Boeckmann, A. Nonmem User's Guide, University of California: San Francisco, 1999.
17. Holford, N. H. Clin. Pharmacokinet., 1996, 30, 329.
18. Anderson, B. J.; Nolford, N. H. Annu. Rev. Pharmacol. Toxicol., 2008, 48, 303.
19. West, G. B.; Brown, J. H.; Enquist, B. J. Science, 1999, 284, 1677.
20. West, G. B.; Brown, J. H.; Enquist, B. J. Science, 1997, 276, 122.
21. Cockcroft, D. W.; Gault, M. H. Nephron, 1976, 16, 31.
22. de Hoog, M.; Mouton, J. W.; Van den Anker, J. N. Semin. Fetal Neonatal Med., 2005, 10, 185.
23. Bartelink, I. H.; Rademaker, C. M.; Schobben, A. F.; Van den Anker, J. N. Clin. Pharmacokinet., 2006, 45, 1077.
24. Van den Anker, J. Semin. Fetal Neonatal Med., 2005, 10, 73.